Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AIN | US
1.46
1.68%
Consumer Cyclical
Textile Manufacturing
30/06/2024
19/09/2024
88.47
89.66
89.66
87.69
Albany International Corp. together with its subsidiaries engages in the textile and materials processing business. The company operates in two segments Machine Clothing (MC) and Albany Engineered Composites (AEC). The MC segment designs manufactures and markets paper machine clothing for use in the manufacturing of papers paperboards tissues towels nonwovens building products tannery and textiles. This segment offers forming pressing and drying fabrics as well as process belts; and engineered fabrics. The AEC segment 3D-woven and injected composite components for aircraft engines composite airframe and engine components for military and commercial aircraft. It operates in the United States Switzerland Brazil China France Mexico Italy and internationally. The company was incorporated in 1895 and is headquartered in Rochester New Hampshire.
View LessLow 6-Month Volatility (<30%)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
24.4%1 month
27.4%3 months
28.8%6 months
29.1%24.41
-
2.76
0.39
0.22
10.99
2.34
2.00
265.62M
2.76B
2.76B
1.23
13.51
-7.30
21.10
11.62
2.37
1.45
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
7.52
Range1M
12.06
Range3M
14.22
Rel. volume
0.73
Price X volume
9.03M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bausch Health Companies Inc | BHC | Drug Manufacturers-Specialty & Generic | 8.18 | 3.00B | 2.00% | n/a | -1843.40% |
Amneal Pharmaceuticals Inc | AMRX | Drug Manufacturers-Specialty & Generic | 8.81 | 2.73B | 1.15% | n/a | -4742.26% |
Catalyst Pharmaceuticals Inc | CPRX | Drug Manufacturers-Specialty & Generic | 21.35 | 2.53B | 4.50% | 36.11 | 0.55% |
Amphastar Pharmaceuticals Inc | AMPH | Drug Manufacturers-Specialty & Generic | 50.09 | 2.45B | 0.62% | 15.27 | 87.00% |
Alignment Healthcare Inc. Common Stock | ALHC | Healthcare Plans | 11.39 | 2.18B | 0.09% | n/a | 177.78% |
PAR Technology Corporation | PAR | Drug Manufacturers-Specialty & Generic | 57.16 | 2.07B | 1.29% | n/a | 65.19% |
Patterson Companies Inc | PDCO | Medical Distribution | 22.26 | 1.96B | 1.37% | 12.08 | 94.43% |
Supernus Pharmaceuticals Inc | SUPN | Drug Manufacturers-Specialty & Generic | 32.13 | 1.77B | 0.91% | 345.67 | 4.18% |
Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 46.47 | 1.65B | 2.51% | n/a | 331.16% |
Clover Leaf Financial Corp | CLOV | Healthcare Plans | 3.03 | 1.51B | 1.00% | n/a | 1.23% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 10.99 | - | - |
Ent. to Revenue | 2.34 | - | - |
PE Ratio | 24.41 | - | - |
Price to Book | 2.76 | - | - |
Dividend Yield | 1.23 | - | - |
Std. Deviation (3M) | 28.78 | - | - |
Debt to Equity | 0.39 | - | - |
Debt to Assets | 0.22 | - | - |
Market Cap | 2.76B | - | - |